Drug profile · INN
ceftazidime sodium
FORTAZ IN PLASTIC CONTAINER
ceftazidime sodium (FORTAZ IN PLASTIC CONTAINER) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — ceftazidime sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ceftazidime sodium (FORTAZ IN PLASTIC CONTAINER) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ceftazidime sodium?
ceftazidime sodium (FORTAZ IN PLASTIC CONTAINER) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ceftazidime sodium?
FORTAZ IN PLASTIC CONTAINER is a marketed brand name for ceftazidime sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ceftazidime sodium?
ceftazidime sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.